Improving HIV prevention strategies for pregnant and breastfeeding women in Malawi
Official title: Project 1 - Surveillance and monitoring systems to identify strategies to improve perinatal practices [Parent Title: PREVENTING INFANT INFECTIONS WITH IMPLEMENTATION SCIENCE IN MALAWI]
Funded at Univ of North Carolina Chapel Hill · NIH-11063847 · Data updated 2026-11-12
This study is looking at how a new HIV prevention method, called Cabotegravir, can help pregnant and breastfeeding women in Malawi stay healthy and avoid getting HIV, while also making sure they get the support they need during this important time.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | May 15, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $338,183 |
| NIH project number | 5P01HD112215-03 |
| Project ID | NIH-11063847 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant and breastfeeding women in sub-Saharan Africa who are at risk of HIV infection.
✕Less likely to help
Patients who are not pregnant or breastfeeding, or those who are already living with HIV, may not benefit from this research.
What this research studies
This research focuses on enhancing antenatal care strategies to prevent new HIV infections among pregnant and breastfeeding women in sub-Saharan Africa, particularly Malawi. It investigates the use of pre-exposure prophylaxis (PrEP), specifically the long-acting injectable Cabotegravir, to reduce HIV acquisition in this vulnerable population. The study aims to address implementation challenges such as poor adherence and follow-up, ensuring that women receive effective HIV prevention during pregnancy and breastfeeding. By gathering safety data on new PrEP options, the research seeks to inform national programs and improve health outcomes for mothers and infants.
Why it matters
Potential benefit: If successful, this research could significantly reduce the rates of new HIV infections among pregnant and breastfeeding women, ultimately preventing mother-to-child transmission.
How similar studies have gone: Previous research has shown promise in using PrEP for HIV prevention, but this specific approach with long-acting injectable options is relatively novel.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Saidi, Friday — Univ of North Carolina Chapel Hill
- Study coordinator: Saidi, Friday
Related research
Other NIH-funded projects on the same topics.
-
Improving colorectal cancer screening and follow-up care.
This study is working to help more people get screened for colorectal cancer and receive the follow-up care they need, especially those who haven't been screened much before, so that everyone can have better access to important health checks and improve their overall health.
-
Making HIV prevention and care easier for Ugandan youth
A Ugandan study is testing ways to help adolescents and young adults (15–24) prevent HIV and stay healthy, using long-acting PrEP and youth-friendly services.
-
Innovative HIV Prevention and Care Interventions for Adolescents and Young Adults in Uganda
A Ugandan research team is testing practical, youth-focused strategies to help 15-24 year-olds using HIV prevention or treatment services stay healthy and engaged in care.
-
How Poverty and the Environment Affect Heart Disease in Haiti and Beyond
This grant studies how poverty-related factors like food insecurity, stress, and pollution contribute to heart disease and aims to follow a large group of adults to better understand and prevent the disease.
-
Resilient HIV Implementation for LGBTQ Youth in Africa and Beyond
A program to help young people ages 15–24 who are at risk for or living with HIV, especially sexual and gender minority youths, access better HIV prevention and care through real-world health practice improvements.
-
Regional hub to speed up ending HIV with practical science
A regional collaboration will translate proven HIV interventions into real-world practice to reduce new infections across priority areas.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.